PSORIATIC ARTHRITIS
Clinical trials for PSORIATIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new PSORIATIC ARTHRITIS trials appear
Sign up with your email to follow new studies for PSORIATIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to tame painful joints and skin in psoriatic arthritis
Disease control OngoingThis study is testing an oral medication called deucravacitinib to see if it safely reduces joint pain, swelling, and skin symptoms in people with active psoriatic arthritis. It involves about 670 participants who have not yet tried advanced biologic drugs. The main goal is to se…
Matched conditions: PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Double attack on arthritis and weight: new combo therapy trial
Disease control OngoingThis study is testing if using two drugs together works better than one for adults with psoriatic arthritis who are also overweight or have obesity. One drug (ixekizumab) treats the arthritis, and the other (tirzepatide) is a weight-loss medication. The goal is to see if the comb…
Matched conditions: PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New shoulder plate aims for fewer repeat surgeries
Disease control OngoingThis study is tracking the safety and performance of a specialized metal plate used to fix broken shoulders. It will follow 135 adults who get this plate after a shoulder fracture to see how well they heal, how much their shoulder moves, and if they need another surgery. The main…
Matched conditions: PSORIATIC ARTHRITIS
Phase: NA • Sponsor: Zimmer Biomet • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New arthritis drug tested for Years-Long relief
Disease control OngoingThis study is checking the long-term safety and effectiveness of an injectable medication called bimekizumab for adults with active psoriatic arthritis. Over 1,100 participants who completed earlier trials will receive the drug for an extended period. The main goal is to see how …
Matched conditions: PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Head-to-Head arthritis drug battle: which works better?
Disease control OngoingThis study compares two medications, bimekizumab and risankizumab, to see which works better for adults with active psoriatic arthritis. Researchers will measure improvements in joint pain, swelling, skin symptoms, and daily function after 16 weeks of treatment. The trial include…
Matched conditions: PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Extended trial tests arthritis Drug's staying power
Disease control OngoingThis study continues monitoring patients who previously participated in tildrakizumab trials for psoriatic arthritis. Researchers are tracking 529 participants to understand the drug's long-term safety and how well it continues to control joint pain and swelling over time. The st…
Matched conditions: PSORIATIC ARTHRITIS
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Phone app aims to Fine-Tune arthritis doctor visits
Disease control OngoingThis study is testing a smartphone app designed to help people with psoriatic arthritis. The app lets patients regularly report their symptoms, which are sent directly to their doctor's electronic health record. Researchers want to see if using this app helps schedule doctor visi…
Matched conditions: PSORIATIC ARTHRITIS
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 04, 2026 15:29 UTC
-
New program aims to bridge healthcare gap for arthritis patients
Disease control OngoingThis study is testing different ways to help people with inflammatory arthritis who face life challenges like unstable housing or transportation issues that make it hard to get medical care. It compares three levels of support: a simple resource list, help from a community specia…
Matched conditions: PSORIATIC ARTHRITIS
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC
-
Massive 5,000-Patient study tracks arthritis treatments in real life
Knowledge-focused ENROLLING_BY_INVITATIONThis study is creating a large registry to track 5,000 patients with psoriatic arthritis or spondyloarthritis over time. Researchers will observe how approved medications work in real-world settings, comparing their effectiveness and safety. The goal is to better understand these…
Matched conditions: PSORIATIC ARTHRITIS
Sponsor: CorEvitas • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Tracking High-Risk pregnancies to unlock better care for women with rare diseases
Knowledge-focused TerminatedThis study aimed to gather information about pregnancy in women with rare autoimmune diseases like lupus and rheumatoid arthritis. Researchers planned to follow these pregnancies to understand complications and how medications affect both mother and baby. The goal was to use this…
Matched conditions: PSORIATIC ARTHRITIS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC